{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:30:54Z","timestamp":1791595854786,"version":"4.3.4"},"reference-count":144,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1AI164560"],"award-info":[{"award-number":["UM1AI164560"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1149990, APP1135851, APP2026490"],"award-info":[{"award-number":["APP1149990, APP1135851, APP2026490"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The \u2018shock and kill\u2019 approach to an HIV cure involves the use of latency reversing agents (LRAs) to reactivate latent HIV, with the aim to induce death of infected cells through virus induced cytolysis or immune mediated clearance. Most LRAs tested to date have been unable to overcome the blocks to transcription elongation and splicing that persist in resting CD4+ T cells. Furthermore, most LRAs target host factors and therefore have associated toxicities. Therefore, there remains a high need for HIV-specific LRAs that can also potently upregulate expression of multiply-spliced HIV RNA and viral protein. The HIV Transactivator of Transcription (Tat) protein plays an important role in viral replication - amplifying transcription from the viral promoter - but it is present at low to negligible levels in latently infected cells. As such, it has been hypothesized that providing Tat in <jats:italic>trans<\/jats:italic> could result in efficient HIV reactivation from latency. Recent studies exploring different types of Tat-based LRAs have used different nanoparticles for Tat delivery and describe potent, HIV-specific induction of multiply-spliced HIV RNA and protein <jats:italic>ex vivo.<\/jats:italic> However, there are several potential challenges to using Tat as a therapeutic, including the ability of Tat to cause systemic toxicities <jats:italic>in vivo<\/jats:italic>, limited delivery of Tat to the HIV reservoir due to poor uptake of nucleic acid by resting cells, and challenges in activating truly transcriptionally silent viruses. Identifying ways to mitigate these challenges will be critical to developing effective Tat-based LRA approaches towards an HIV cure.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1571151","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T05:14:36Z","timestamp":1744348476000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["HIV Tat as a latency reversing agent: turning the tables on viral persistence"],"prefix":"10.3389","volume":"16","author":[{"given":"Bridget M.","family":"Fisher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula M.","family":"Cevaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon R.","family":"Lewin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1925601","article-title":"Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection","volume":"254","author":"Bukrinsky","year":"1991","journal-title":"Science"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.24.13193","article-title":"Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy","volume":"94","author":"Chun","year":"1997","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1126\/science.278.5341.1295","article-title":"Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy","volume":"278","author":"Finzi","year":"1997","journal-title":"Science"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01590-5","article-title":"Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021","volume":"27","author":"Deeks","year":"2021","journal-title":"Nat Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coviro.2019.03.004","article-title":"Between a shock and a hard place: challenges and developments in HIV latency reversal","volume":"38","author":"Zerbato","year":"2019","journal-title":"Curr Opin Virol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005063","article-title":"An in-depth comparison of latency-reversing agent combinations in various in vitro and ex vivo HIV-1 latency models identified bryostatin-1+JQ1 and ingenol-B+JQ1 to potently reactivate viral gene expression","volume":"11","author":"Darcis","year":"2015","journal-title":"PloS Pathog"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.01035","article-title":"A novel bromodomain inhibitor reverses HIV-1 latency through specific binding with BRD4 to promote tat and P-TEFb association","volume":"8","author":"Huang","year":"2017","journal-title":"Front Microbiol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1172\/JCI80142","article-title":"Ex\u00a0vivo analysis identifies effective HIV-1 latency-reversing drug combinations","volume":"125","author":"Laird","year":"2015","journal-title":"J Clin Invest"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-1951-3","article-title":"Systemic HIV and SIV latency reversal via non-canonical NF-kappaB signalling in vivo","volume":"578","author":"Nixon","year":"2020","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01077-15","article-title":"Ex vivo bioactivity and HIV-1 latency reversal by ingenol dibenzoate and panobinostat in resting CD4(+) T cells from aviremic patients","volume":"59","author":"Spivak","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jve.2023.100342","article-title":"The efficacy and tolerability of latency-reversing agents in reactivating the HIV-1 reservoir in clinical studies: a systematic review","volume":"9","author":"Debrabander","year":"2023","journal-title":"J Virus Eradication"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu155","article-title":"HIV-1 expression within resting CD4+ T cells after multiple doses of vorinostat","volume":"210","author":"Archin","year":"2014","journal-title":"J Infect Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(15)00226-X","article-title":"Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study","volume":"2","author":"Elliott","year":"2015","journal-title":"Lancet HIV"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004473","article-title":"Activation of HIV transcription with short-course vorinostat in HIV-Infected patients on suppressive antiretroviral therapy","volume":"10","author":"Elliott","year":"2014","journal-title":"PloS Pathog"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3489","article-title":"New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo","volume":"20","author":"Bullen","year":"2014","journal-title":"Nat Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12977-018-0421-6","article-title":"HIV latency reversing agents act through Tat post translational modifications","volume":"15","author":"Khoury","year":"2018","journal-title":"Retrovirology"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aap9927","article-title":"HIV latency in isolated patient CD4+ T cells may be due to blocks in HIV transcriptional elongation, completion, and splicing","volume":"10","author":"Yukl","year":"2018","journal-title":"Sci Trans Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103241","article-title":"Multiply spliced HIV RNA is a predictive measure of virus production ex vivo and in vivo following reversal of HIV latency","volume":"65","author":"Zerbato","year":"2021","journal-title":"EBioMedicine"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004287","article-title":"Histone deacetylase inhibitors impair the elimination of HIV-infected cells by cytotoxic T-lymphocytes","volume":"10","author":"Jones","year":"2014","journal-title":"PloS Pathog"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-13-0188","article-title":"Exposure to a histone deacetylase inhibitor has detrimental effects on human lymphocyte viability and function","volume":"2","author":"Wong","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(20)30234-4","article-title":"Multi-stakeholder consensus on a target product profile for an HIV cure","volume":"8","author":"Lewin","year":"2021","journal-title":"Lancet HIV"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(24)00277-7","article-title":"Target product profile for cell-based and gene-based therapies to achieve a cure for HIV","volume":"12","author":"Lewin","year":"2025","journal-title":"Lancet HIV"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/313277a0","article-title":"Complete nucleotide sequence of the AIDS virus, HTLV-III","volume":"313","author":"Ratner","year":"1985","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkq037","article-title":"Modifications in host cell cytoskeleton structure and function mediated by intracellular HIV-1 Tat protein are greatly dependent on the second coding exon","volume":"38","author":"Lopez-Huertas","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.virusres.2018.04.008","article-title":"The evolution of subtype B HIV-1 tat in the Netherlands during 1985-2012","volume":"250","author":"van der Kuyl","year":"2018","journal-title":"Virus Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.41.28837","article-title":"Multifaceted activities of the HIV-1 transactivator of transcription, Tat","volume":"274","author":"Jeang","year":"1999","journal-title":"J Biol Chem"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/17.9.3551","article-title":"Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis","volume":"17","author":"Kuppuswamy","year":"1989","journal-title":"Nucleic Acids Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.23.9224","article-title":"Missense mutations in an infectious human immunodeficiency viral genome: functional mapping of tat and identification of the rev splice acceptor","volume":"85","author":"Sadaie","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1997.8786","article-title":"Determination of the minimal amount of Tat activity required for human immunodeficiency virus type 1 replication","volume":"237","author":"Verhoef","year":"1997","journal-title":"Virology"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.63.3.1181-1187.1989","article-title":"Mutational analysis of the conserved basic domain of human immunodeficiency virus tat protein","volume":"63","author":"Hauber","year":"1989","journal-title":"J Virol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M406195200","article-title":"The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis","volume":"279","author":"Campbell","year":"2004","journal-title":"J Biol Chem"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2007.03.004","article-title":"Human immunodeficiency virus type-1 protein Tat induces tumor necrosis factor-alpha-mediated neurotoxicity","volume":"26","author":"Buscemi","year":"2007","journal-title":"Neurobiol Dis"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0607405","article-title":"NF-kappaB-dependent control of HIV-1 transcription by the second coding exon of Tat in T cells","volume":"83","author":"Mahlknecht","year":"2008","journal-title":"J\u00a0Leukoc Biol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1159\/000073531","article-title":"Requirement for the second coding exon of Tat in the optimal replication of macrophage-tropic HIV-1","volume":"10","author":"Neuveut","year":"2003","journal-title":"J\u00a0BioMed Sci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.17.7941","article-title":"The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence","volume":"90","author":"Barillari","year":"1993","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.7.2157","article-title":"Human immunodeficiency viral long terminal repeat is functional and can be trans-activated in Escherichia coli","volume":"86","author":"Kashanchi","year":"1989","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/334165a0","article-title":"HIV-1 tat trans-activation requires the loop sequence within tar","volume":"334","author":"Feng","year":"1988","journal-title":"Nature"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.20.14.5077-5086.2000","article-title":"Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription","volume":"20","author":"Zhou","year":"2000","journal-title":"Mol Cell Biol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.184711","article-title":"Variation in HIV-1 Tat activity is a key determinant in the establishment of latent infection","volume":"10","author":"Gomez-Rivera","year":"2024","journal-title":"JCI Insight"},{"key":"B40","doi-asserted-by":"publisher","first-page":"4503","DOI":"10.1038\/s41467-021-24462-5","article-title":"Stochastic pausing at latent HIV-1 promoters generates transcriptional bursting","volume":"12","author":"Tantale","year":"2021","journal-title":"Nat\u00a0Commun"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2005.06.006","article-title":"Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity","volume":"122","author":"Weinberger","year":"2005","journal-title":"Cell"},{"key":"B42","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.cell.2015.02.009","article-title":"A hardwired HIV latency program","volume":"160","author":"Razooky","year":"2015","journal-title":"Cell"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1042\/cbi20090376","article-title":"HIV-1 Tat is unconventionally secreted through the plasma membrane","volume":"34","author":"Rayne","year":"2010","journal-title":"Cell Biol Int"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2010.32","article-title":"Phosphatidylinositol-(4,5)-bisphosphate enables efficient secretion of HIV-1 Tat by infected T-cells","volume":"29","author":"Rayne","year":"2010","journal-title":"EMBO J"},{"key":"B45","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1038\/s41598-019-39531-5","article-title":"A naturally occurring polymorphism in the HIV-1 tat basic domain inhibits uptake by bystander cells and leads to reduced neuroinflammation","volume":"9","author":"Ruiz","year":"2019","journal-title":"Sci Rep"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(88)90262-0","article-title":"Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein","volume":"55","author":"Green","year":"1988","journal-title":"Cell"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2184.2007.00470.x","article-title":"Photochemically enhanced delivery of a cell-penetrating peptide nucleic acid conjugate targeting human telomerase reverse transcriptase: Effects on telomere status and proliferative potential of human prostate cancer cells","volume":"40","author":"Folini","year":"2007","journal-title":"Cell Proliferation"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.1014","article-title":"Recombinant fusion proteins TAT-Mu, Mu and Mu-Mu mediate efficient non-viral gene delivery","volume":"9","author":"Rajagopalan","year":"2007","journal-title":"J Gene Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1172\/JCI25052","article-title":"TAT-mediated intracellular delivery of purine nucleoside phosphorylase corrects its deficiency in mice","volume":"116","author":"Toro","year":"2006","journal-title":"J Clin Invest"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.06648-11","article-title":"The viral protein tat can inhibit the establishment of HIV-1 latency","volume":"86","author":"Donahue","year":"2012","journal-title":"J Virol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00417-23","article-title":"A truncated HIV Tat demonstrates potent and specific latency reversal activity","volume":"67","author":"Van Gulck","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M006701200","article-title":"Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans","volume":"276","author":"Tyagi","year":"2001","journal-title":"J Biol Chem"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.023705","article-title":"Mechanism for HIV-1 tat insertion into the endosome membrane","volume":"284","author":"Yezid","year":"2009","journal-title":"J Biol Chem"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/345084a0","article-title":"Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients","volume":"345","author":"Ensoli","year":"1990","journal-title":"Nature"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002268","article-title":"Presence of Tat and transactivation response element in spinal fluid despite antiretroviral therapy","volume":"33","author":"Henderson","year":"2019","journal-title":"AIDS"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1308673110","article-title":"Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein","volume":"110","author":"Johnson","year":"2013","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.106","article-title":"HIV Tat induces a prolonged MYC relocalization next to IGH in circulating B-cells","volume":"31","author":"Germini","year":"2017","journal-title":"Leukemia"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-08-2928","article-title":"Migration of V delta 1 and V delta 2 T cells in response to CXCR3 and CXCR4 ligands in healthy donors and HIV-1-infected patients: competition by HIV-1 Tat","volume":"103","author":"Poggi","year":"2004","journal-title":"Blood"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2024.106994","article-title":"HIV-1 Tat is present in the serum of people living with HIV-1 despite viral suppression","volume":"142","author":"Shmakova","year":"2024","journal-title":"Int J Infect Dis"},{"key":"B60","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/375497a0","article-title":"Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120","volume":"375","author":"Westendorp","year":"1995","journal-title":"Nature"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.21.11466","article-title":"Selective CXCR4 antagonism by Tat: Implications for in vivo expansion of coreceptor use by HIV-1","volume":"97","author":"Xiao","year":"2000","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2004.11.019","article-title":"Permeability of the blood-brain barrier to HIV-1 Tat","volume":"193","author":"Banks","year":"2005","journal-title":"Exp Neurol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.77.15.8227-8236.2003","article-title":"Transcriptional profiles of latent human immunodeficiency virus in infected individuals: effects of tat on the host and reservoir","volume":"77","author":"Lin","year":"2003","journal-title":"J Virol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.15174","article-title":"Tat is a multifunctional viral protein that modulates cellular gene expression and functions","volume":"8","author":"Clark","year":"2017","journal-title":"Oncotarget"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.23.14883","article-title":"HIV-1 Tat induces the expression of the interleukin-6 (IL6) gene by binding to the IL6 leader RNA and by interacting with CAAT enhancer-binding protein beta (NF-IL6) transcription factors","volume":"272","author":"Ambrosino","year":"1997","journal-title":"J Biol Chem"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.68.4.2677-2682.1994","article-title":"The human immunodeficiency virus type 1 Tat protein transactivates tumor necrosis factor beta gene expression through a TAR-like structure","volume":"68","author":"Buonaguro","year":"1994","journal-title":"J Virol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-10-461566","article-title":"Tat engagement of p38 MAP kinase and IRF7 pathways leads to activation of interferon-stimulated genes in antigen-presenting cells","volume":"121","author":"Kim","year":"2013","journal-title":"Blood"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.25.5.1620-1633.2005","article-title":"Displacement of SATB1-bound histone deacetylase 1 corepressor by the human immunodeficiency virus type 1 transactivator induces expression of interleukin-2 and its receptor in T cells","volume":"25","author":"Kumar","year":"2005","journal-title":"Mol Cell Biol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.08955","article-title":"HIV Tat controls RNA Polymerase II and the epigenetic landscape to transcriptionally reprogram target immune cells","volume":"4","author":"Reeder","year":"2015","journal-title":"eLife"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.07215-11","article-title":"Expression of human endogenous retrovirus type K (HML-2) is activated by the Tat protein of HIV-1","volume":"86","author":"Gonzalez-Hernandez","year":"2012","journal-title":"J Virol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.662573","article-title":"Infection by diverse HIV-1 subtypes leads to different elevations in HERV-K transcriptional levels in human T cell lines","volume":"12","author":"Li","year":"2021","journal-title":"Front Microbiol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000477","article-title":"HIV Tat acts on endogenous retroviruses of the W family and this occurs via Toll-like receptor 4: inference for neuroAIDS","volume":"28","author":"Uleri","year":"2014","journal-title":"AIDS"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001734","article-title":"The HIV-1 Tat protein affects human CD4+ T-cell programing and activation, and favors the differentiation of na\u00efve CD4+ T cells","volume":"32","author":"Nicoli","year":"2018","journal-title":"AIDS"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3390\/v14102191","article-title":"HIV-1 tat upregulates the receptor for advanced glycation end products and superoxide dismutase-2 in the heart of transgenic mice","volume":"14","author":"Qrareya","year":"2022","journal-title":"Viruses"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2018.1476810","article-title":"HIV-1 TAT-mediated microglial activation: role of mitochondrial dysfunction and defective mitophagy","volume":"14","author":"Thangaraj","year":"2018","journal-title":"Autophagy"},{"key":"B76","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.mcn.2004.07.003","article-title":"Astrocyte activation and dysfunction and neuron death by HIV-1 Tat expression in astrocytes","volume":"27","author":"Zhou","year":"2004","journal-title":"Mol Cell Neurosci"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.22.13153","article-title":"HIV-1 Tat protein mimicry of chemokines","volume":"95","author":"Albini","year":"1998","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-020-03561-4","article-title":"Functional impact of HIV-1 Tat on cells of the CNS and its role in HAND","volume":"77","author":"Marino","year":"2020","journal-title":"Cell Mol Life sciences: CMLS"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2020.00168","article-title":"Extracellular HIV-1 tat mediates increased glutamate in the CNS leading to onset of senescence and progression of HAND","volume":"12","author":"Marino","year":"2020","journal-title":"Front Aging Neurosci"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/cdg188","article-title":"HIV reproducibly establishes a latent infection after acute infection of T cells in vitro","volume":"22","author":"Jordan","year":"2003","journal-title":"EMBO J"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2020.07.141","article-title":"Physicochemical studies on the structural stability of the HIV-1 vaccine candidate recombinant Tat protein","volume":"164","author":"Falahati","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.95676","article-title":"Exosomal Tat protein activates latent HIV-1 in primary, resting CD4+ T lymphocytes","volume":"3","author":"Tang","year":"2018","journal-title":"JCI Insight"},{"key":"B83","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s13346-022-01225-3","article-title":"The exosome: a review of current therapeutic roles and capabilities in human reproduction","volume":"13","author":"Dimik","year":"2023","journal-title":"Drug Delivery Transl Res"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.27207","article-title":"Impact of exosomal HIV-1 Tat expression on the human cellular proteome","volume":"10","author":"Lu","year":"2019","journal-title":"Oncotarget"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.200500437","article-title":"Modifications in the human T cell proteome induced by intracellular HIV-1 Tat protein expression","author":"Coiras","year":"2006","journal-title":"Proteomics"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.201600236","article-title":"Quantitative proteomic analysis of HIV-1 Tat-induced dysregulation in SH-SY5Y neuroblastoma cells","volume":"17","author":"Ganief","year":"2017","journal-title":"Proteomics"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0048702","article-title":"Nucleolar protein trafficking in response to HIV-1 tat: rewiring the nucleolus","volume":"7","author":"Jarboui","year":"2012","journal-title":"PloS One"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1021\/pr300173c","article-title":"Combined metabonomic and quantitative real-time PCR analyses reveal systems metabolic changes in Jurkat T-cells treated with HIV-1 tat protein","volume":"11","author":"Liao","year":"2012","journal-title":"J Proteome Res"},{"key":"B89","doi-asserted-by":"publisher","first-page":"8397","DOI":"10.1038\/s41467-023-44020-5","article-title":"Potent latency reversal by Tat RNA-containing nanoparticle enables multi-omic analysis of the HIV-1 reservoir","volume":"14","author":"Pardons","year":"2023","journal-title":"Nat Commun"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00201-24","article-title":"Nanoparticle delivery of Tat synergizes with classical latency reversal agents to express HIV antigen targets","volume":"68","author":"Raines","year":"2024","journal-title":"Antimicrobial Agents Chemotherapy"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2022.167880","article-title":"Structural insights into the mechanism of HIV-1 tat secretion from the plasma membrane","volume":"435","author":"Ghanam","year":"2023","journal-title":"J Mol Biol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.24.13003","article-title":"The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: Peptoid molecular transporters","volume":"97","author":"Wender","year":"2000","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B93","doi-asserted-by":"publisher","first-page":"64","DOI":"10.2174\/1570162x13666150121111548","article-title":"Didehydro-cortistatin A inhibits HIV-1 tat mediated neuroinflammation and prevents potentiation of cocaine reward in tat transgenic mice","volume":"13","author":"Mediouni","year":"2015","journal-title":"Curr HIV Res"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2016.117","article-title":"Development of an attenuated tat protein as a highly-effective agent to specifically activate HIV-1 latency","volume":"24","author":"Geng","year":"2016","journal-title":"Mol Ther"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.7150\/thno.27891","article-title":"Membrane radiolabelling of exosomes for comparative biodistribution analysis in immunocompetent and immunodeficient mice - A novel and universal approach","volume":"9","author":"Faruqu","year":"2019","journal-title":"Theranostics"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2016.07.022","article-title":"Role of phosphatidylserine-derived negative surface charges in the recognition and uptake of intravenously injected B16BL6-derived exosomes by macrophages","volume":"106","author":"Matsumoto","year":"2017","journal-title":"J Pharm Sci"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13030427","article-title":"Biodistribution and pharmacokinectics of liposomes and exosomes in a mouse model of sepsis","volume":"13","author":"Mirzaaghasi","year":"2021","journal-title":"Pharmaceutics"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.7150\/thno.39434","article-title":"Tumor cell-derived exosomes home to their cells of origin and can be used as Trojan horses to deliver cancer drugs","volume":"10","author":"Qiao","year":"2020","journal-title":"Theranostics"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2019.102072","article-title":"Differential in vivo biodistribution of 131I-labeled exosomes from diverse cellular origins and its implication for theranostic application","volume":"21","author":"Rashid","year":"2019","journal-title":"Nanomedicine: Nanotechnology Biology Med"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2014.12.013","article-title":"Biodistribution and delivery efficiency of unmodified tumor-derived exosomes","volume":"199","author":"Smyth","year":"2015","journal-title":"J\u00a0Controlled Release"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3402\/jev.v4.26316","article-title":"Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting","volume":"4","author":"Wiklander","year":"2015","journal-title":"J Extracellular Vesicles"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3402\/jev.v4.26238","article-title":"Macrophage-dependent clearance of systemically administered B16BL6-derived exosomes from the blood circulation in mice","volume":"4","author":"Imai","year":"2015","journal-title":"J Extracellular Vesicles"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1369\/0022155411410885","article-title":"Biodistribution of small interfering RNA at the organ and cellular levels after lipid nanoparticle-mediated delivery","volume":"59","author":"Shi","year":"2011","journal-title":"J Histochem Cytochem"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.121339","article-title":"In situ T-cell transfection by anti-CD3-conjugated lipid nanoparticles leads to T-cell activation, migration, and phenotypic shift","volume":"281","author":"Kheirolomoom","year":"2022","journal-title":"Biomaterials"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.5b02796","article-title":"Systemic gene silencing in primary T lymphocytes using targeted lipid nanoparticles","volume":"9","author":"Ramishetti","year":"2015","journal-title":"ACS Nano"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2021.06.004","article-title":"Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs","volume":"29","author":"Tomb\u00e1cz","year":"2021","journal-title":"Mol Ther"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2022.05.020","article-title":"Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells","volume":"347","author":"Patel","year":"2022","journal-title":"J Control Release"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat Nanotechnology"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2022.03.046","article-title":"The replacement of helper lipids with charged alternatives in lipid nanoparticles facilitates targeted mRNA delivery to the spleen and lungs","volume":"345","author":"LoPresti","year":"2022","journal-title":"J Controlled Release"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2024.114266","article-title":"Lipid nanoparticles for local delivery of mRNA to the respiratory tract: Effect of PEG-lipid content and administration route","volume":"198","author":"Ongun","year":"2024","journal-title":"Eur J Pharmaceutics Biopharmaceutics"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202304378","article-title":"In vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism","volume":"20","author":"Billingsley","year":"2024","journal-title":"Small"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.add4623","article-title":"Peptide-guided lipid nanoparticles deliver mRNA to the neural retina of rodents and nonhuman primates","volume":"9","author":"Herrera-Barrera","year":"2023","journal-title":"Sci Adv"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1126\/science.abm0594","article-title":"CAR T cells produced in vivo to treat cardiac injury","volume":"375","author":"Rurik","year":"2022","journal-title":"Science"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.0c09514","article-title":"In vivo T cell-targeting nanoparticle drug delivery systems: considerations for rational design","volume":"15","author":"Cevaal","year":"2021","journal-title":"ACS Nano"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4411","article-title":"Defining total-body AIDS-virus burden with implications for curative strategies","volume":"23","author":"Estes","year":"2017","journal-title":"Nat\u00a0Med"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01612-22","article-title":"A single dose of anti-HBsAg antibody-encoding mRNA-LNPs suppressed HBsAg expression: a potential cure of chronic hepatitis B virus infection","volume":"13","author":"Chen","year":"2022","journal-title":"mBio"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.9b01182","article-title":"The effect of size and charge of lipid nanoparticles prepared by microfluidic mixing on their lymph node transitivity and distribution","volume":"17","author":"Nakamura","year":"2020","journal-title":"Mol Pharmaceutics"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.04.007","article-title":"Targeted delivery of immunomodulators to lymph nodes","volume":"15","author":"Azzi","year":"2016","journal-title":"Cell Rep"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2017.09.040","article-title":"Rifampicin Lipid-Polymer hybrid nanoparticles (LIPOMER) for enhanced Peyer's patch uptake","volume":"532","author":"Bachhav","year":"2017","journal-title":"Int J Pharmaceutics"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2022.10.020","article-title":"The feasibility of oral targeted drug delivery: Gut immune to particulates","volume":"13","author":"Ren","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.40.3.648","article-title":"Junctions between intimately apposed cell membranes in the vertebrate brain","volume":"40","author":"Brightman","year":"1969","journal-title":"J Cell Biol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21124407","article-title":"Transport of extracellular vesicles across the blood-brain barrier: Brain pharmacokinetics and effects of inflammation","volume":"21","author":"Banks","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.7b01084","article-title":"In Vivo Introduction of mRNA Encapsulated in Lipid Nanoparticles to Brain Neuronal Cells and Astrocytes via Intracerebroventricular Administration","volume":"15","author":"Tanaka","year":"2018","journal-title":"Mol Pharmaceutics"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biochem.3c00371","article-title":"Lipid Nanoparticles Deliver mRNA to the Brain after an Intracerebral Injection","volume":"62","author":"Tuma","year":"2023","journal-title":"Biochemistry"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1007\/s12274-024-6827-7","article-title":"Lipid nanoparticles deliver mRNA to the blood-brain barrier","volume":"62","author":"Kuzminich","year":"2024","journal-title":"Nano Res"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.09.081","article-title":"Identification of genetically intact HIV-1 proviruses in specific CD4(+) T cells from effectively treated participants","volume":"21","author":"Hiener","year":"2017","journal-title":"Cell Rep"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.09.020","article-title":"Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure","volume":"155","author":"Ho","year":"2013","journal-title":"Cell"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1038\/387183a0","article-title":"Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection","volume":"387","author":"Chun","year":"1997","journal-title":"Nature"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003174","article-title":"Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies","volume":"9","author":"Eriksson","year":"2013","journal-title":"PloS Pathog"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20170193","article-title":"Proliferation of latently infected CD4+ T cells carrying replication-competent HIV-1: Potential role in latent reservoir dynamics","volume":"214","author":"Hosmane","year":"2017","journal-title":"J Exp Med"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.12.011","article-title":"Parallel analysis of transcription, integration, and sequence of single HIV-1 proviruses","volume":"185","author":"Einkauf","year":"2022","journal-title":"Cell"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4113","article-title":"PD-1+ and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals","volume":"22","author":"Banga","year":"2016","journal-title":"Nat Med"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1056\/nejm199905273402102","article-title":"Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy","volume":"340","author":"Furtado","year":"1999","journal-title":"New Engl J Med"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.73.7.6099-6103.1999","article-title":"Use of real-time PCR and molecular beacons to detect virus replication in human immunodeficiency virus type 1-infected individuals on prolonged effective antiretroviral therapy","volume":"73","author":"Lewin","year":"1999","journal-title":"J Virol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008490","article-title":"Cellular levels of HIV unspliced RNA from patients on combination antiretroviral therapy with undetectable plasma viremia predict the therapy outcome","volume":"4","author":"Pasternak","year":"2009","journal-title":"PloS One"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2023.08.006","article-title":"Spontaneous HIV expression during suppressive ART is associated with the magnitude and function of HIV-specific CD4+ and CD8+ T cells","volume":"31","author":"Dub\u00e9","year":"2023","journal-title":"Cell Host Microbe"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab121","article-title":"Gag p24 is a marker of human immunodeficiency virus expression in tissues and correlates with immune response","volume":"224","author":"Wu","year":"2021","journal-title":"J Infect Dis"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2023.10.002","article-title":"Single-cell epigenetic, transcriptional, and protein profiling of latent and active HIV-1 reservoir revealed that IKZF3 promotes HIV-1 persistence","volume":"56","author":"Wei","year":"2023","journal-title":"Immunity"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1617961114","article-title":"Single-cell analysis of HIV-1 transcriptional activity reveals expression of proviruses in expanded clones during ART","volume":"114","author":"Wiegand","year":"2017","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05556-6","article-title":"HIV silencing and cell survival signatures in infected T cell reservoirs","volume":"614","author":"Clark","year":"2023","journal-title":"Nature"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2022.03.004","article-title":"Single-cell multiomics reveals persistence of HIV-1 in expanded cytotoxic T cell clones","volume":"55","author":"Collora","year":"2022","journal-title":"Immunity"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-022-01371-3","article-title":"Profound phenotypic and epigenetic heterogeneity of the HIV-1-infected CD4(+) T cell reservoir","volume":"24","author":"Wu","year":"2023","journal-title":"Nat Immunol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101178","article-title":"Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice","volume":"4","author":"Arandjelovic","year":"2023","journal-title":"Cell Rep Med"},{"key":"B144","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.chom.2017.12.004","article-title":"Getting the \"Kill\" into \"Shock and kill\": strategies to eliminate latent HIV","volume":"23","author":"Kim","year":"2018","journal-title":"Cell Host Microbe"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1571151\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T05:14:37Z","timestamp":1744348477000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1571151\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":144,"alternative-id":["10.3389\/fimmu.2025.1571151"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1571151","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,11]]},"article-number":"1571151"}}